Federal Register / Vol. 77, No. 206 / Wednesday, October 24, 2012 / Notices 64997 

of Compensation Analysis and Support, 

NIOSH, 4676 Columbia Parkway, MS C– 

46, Cincinnati, OH 45226, Telephone 1– 

877–222–7570. Information requests can 

also be submitted by email to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2012–26172 Filed 10–23–12; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Childhood 

Lead Poisoning Prevention 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned committee: 

Times and Dates 

9:00 a.m.–4:00 p.m., November 14, 2012 

8:45 a.m.–4:30 p.m., November 15, 2012 

9:15 a.m.–12:00 p.m., November 16, 

2012 

Place: CDC, Chamblee Campus, 

Building 106, 1st Floor, Conference 

Rooms 1A/B, 4770 Buford Highway, 

NE., Atlanta, Georgia 30341. 

Status 

This meeting is open to the public, 

limited only by the space available. The 

meeting room accommodates 

approximately 75 people. Opportunities 

will be provided during the meeting for 

oral comments. 

Purpose 

The Committee provides advice and 

guidance to the Secretary; the Assistant 

Secretary for Health; and the Director, 

CDC, regarding new scientific 

knowledge and technological 

developments and their practical 

implications for childhood lead 

poisoning prevention efforts. The 

committee also reviews and reports 

regularly on childhood lead poisoning 

prevention practices and recommends 

improvements in national childhood 

lead poisoning prevention efforts. 

Matters To Be Discussed 

Agenda items will include the 

following: Childhood Lead Poisoning 

Prevention Update—Status of our 35 

Programs; evaluation of services for 

children in Chicago; scientific program 

presentation costs and benefits of smoke 

free policies in public housing; 

Laboratory Workgroup updates; 

Educational Intervention Workgroup 

presentation; Agency updates and 

Response to ACCLPP 

Recommendations; Federal agency 

updates; HUD Guidelines (Second 

Edition); Lead-based paint/hazards 

standard review; Spot Test Kit update 

and international work. 

Agenda items are subject to change as 

priorities dictate. 

Supplemental Information: The 

public comment period is scheduled on 

Wednesday, November 14, 2012, from 

3:45 p.m.–4:00 p.m.; on Thursday, 

November 15, 2012, from 4:15 p.m.–4:30 

p.m.; and on Friday, November 16, 

2012, from 11:45 a.m.–12:00 p.m. 

Contact Person for More Information 

Sandra Malcom, Committee 

Management Specialist, NCEH/ATSDR, 

CDC, 4770 Buford Highway, Mail Stop 

F–61, Chamblee, Georgia 30345, 

Telephone: (770) 488–0575, Fax: (770) 

488–3377, Email: smalcom@cdc.gov. 

The deadline for notification of 

attendance is November 9, 2012. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: October 17, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–26274 Filed 10–23–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3275–N] 

Medicare Program; Meeting of the 

Medicare Evidence Development and 

Coverage Advisory Committee— 

January 30, 2013 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces that a 

public meeting of the Medicare 

Evidence Development & Coverage 

Advisory Committee (MEDCAC) 

(‘‘Committee’’) will be held on 

Wednesday, January 30, 2013. The 

Committee generally provides advice 

and recommendations concerning the 

adequacy of scientific evidence needed 

to determine whether certain medical 

items and services can be covered under 

the Medicare statute. This meeting will 

focus on beta amyloid positron emission 

tomography in dementia and 

neurodegenerative disease. This meeting 

is open to the public in accordance with 

the Federal Advisory Committee Act (5 

U.S.C. App. 2, section 10(a)). 

DATES: Meeting Date: The public 

meeting will be held on Wednesday, 

January 30, 2013 from 7:30 a.m. until 

4:30 p.m., Eastern Standard Time (EST). 

Deadline for Submission of Written 

Comments: Written comments must be 

received at the address specified in the 

ADDRESSES section of this notice by 5 

p.m., EST, Monday, December 17, 2012. 

Once submitted, all comments are final. 

Deadlines for Speaker Registration 

and Presentation Materials: The 

deadline to register to be a speaker and 

to submit PowerPoint presentation 

materials and writings that will be used 

in support of an oral presentation is 5:00 

p.m., EST on Monday, December 17, 

2012. Speakers may register by phone or 

via email by contacting the person listed 

in the FOR FURTHER INFORMATION

CONTACT section of this notice. 

Presentation materials must be received 

at the address specified in the 

ADDRESSES section of this notice. 

Deadline for All Other Attendees 

Registration: Individuals may register 

online at http://www.cms.gov/apps/ 

events/upcomingevents.asp?strOrder

By=1&type=3 or by phone by contacting 

the person listed in the FOR FURTHER

INFORMATION CONTACT section of this 

notice by 5 p.m. EST, Wednesday, 

January 23, 2013. 

We will be broadcasting the meeting 

live via Webcast at http://www.cms.gov/ 

live/. 

Deadline for Submitting a Request for 

Special Accommodations: Persons 

attending the meeting who are hearing 

or visually impaired, or have a 

condition that requires special 

assistance or accommodations, are 

asked to contact the Executive Secretary 

as specified in the FOR FURTHER

INFORMATION CONTACT section of this 

notice no later than 5:00 p.m., EST 

Friday, January 11, 2013. 

ADDRESSES: Meeting Location: The 

meeting will be held in the main 

auditorium of the Centers for Medicare 

& Medicaid Services, 7500 Security 

Boulevard, Baltimore, MD 21244. 

Submission of Presentations and 

Comments: Presentation materials and 

written comments that will be presented 

at the meeting must be submitted via 


wreier-aviles on DSK5TPTVN1PROD with 
64998 Federal Register / Vol. 77, No. 206 / Wednesday, October 24, 2012 / Notices 

email to MedCACpresentations@

cms.hhs.gov or by regular mail to the 

contact listed in the FOR FURTHER

INFORMATION CONTACT section of this 

notice by the date specified in the DATES

section of this notice. 

FOR FURTHER INFORMATION CONTACT: 

Maria Ellis, Executive Secretary for 

MEDCAC, Centers for Medicare & 

Medicaid Services, Center for Clinical 

Standards and Quality, Coverage and 

Analysis Group, S3–02–01, 7500 

Security Boulevard, Baltimore, MD 

21244 or contact Ms. Ellis by phone 

(410–786–0309) or via email at 

Maria.Ellis@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

MEDCAC, formerly known as the 

Medicare Coverage Advisory Committee 

(MCAC), provides advice and 

recommendations to CMS regarding 

clinical issues. (For more information 

on MCAC, see the December 14, 1998 

Federal Register (63 FR 68780). This 

notice announces the Wednesday, 

January 30, 2013, public meeting of the 

Committee. During this meeting, the 

Committee will discuss beta amyloid 

positron emission tomography in 

dementia and neurodegenerative 

disease. Background information about 

this topic, including panel materials, is 

available at http://www.cms.gov/

medicare-coverage-database/indexes/ 

medcac-meetings-index.aspx?bc=BAA

AAAAAAAAA&. CMS will no longer be 

providing paper copies of the handouts 

for the meeting. Electronic copies of all 

the meeting materials will be on the 

CMS Web site no later than 2 business 

days before the meeting. We encourage 

the participation of appropriate 

organizations with expertise in beta 

amyloid positron emission tomography 

in dementia and neurodegenerative 

disease. 

II. Meeting Format 

This meeting is open to the public. 

The Committee will hear oral 

presentations from the public for 

approximately 45 minutes. Time 

allotted for each presentation may be 

limited. If the number of registrants 

requesting to speak is greater than can 

be reasonably accommodated during the 

scheduled open public hearing session, 

CMS may conduct a lottery to determine 

the speakers for the scheduled open 

public hearing session. The contact 

person will notify interested persons 

regarding their request to speak by 

December 20, 2012. Your comments 

should focus on issues specific to the 

list of topics that we have proposed to 

the Committee. The list of research 

topics to be discussed at the meeting 

will be available on the following Web 

site prior to the meeting: http://

www.cms.gov/medicare-coveragedatabase/indexes/medcac-meetingsindex.aspx?bc=BAAAAAAAAAAA&. 

We require that you declare at the 

meeting whether you have any financial 

involvement with manufacturers (or 

their competitors) of any items or 

services being discussed. 

The Committee will deliberate openly 

on the topics under consideration. 

Interested persons may observe the 

deliberations, but the Committee will 

not hear further comments during this 

time except at the request of the 

chairperson. The Committee will also 

allow a 15-minute unscheduled open 

public session for any attendee to 

address issues specific to the topics 

under consideration. At the conclusion 

of the day, the members will vote and 

the Committee will make its 

recommendation(s) to CMS. 

III. Registration Instructions 

CMS’ Coverage and Analysis Group is 

coordinating meeting registration. While 

there is no registration fee, individuals 

must register to attend. You may register 

online at http://www.cms.gov/apps/ 

events/upcomingevents.asp?strOrder

By=1&type=3 or by phone by contacting 

the person listed in the FOR FURTHER

INFORMATION CONTACT section of this 

notice by the deadline listed in the 

DATES section of this notice. Please 

provide your full name (as it appears on 

your state-issued driver’s license), 

address, organization, telephone, fax 

number(s), and email address. You will 

receive a registration confirmation with 

instructions for your arrival at the CMS 

complex or you will be notified that the 

seating capacity has been reached. 

IV. Security, Building, and Parking 

Guidelines 

This meeting will be held in a federal 

government building; therefore, federal 

security measures are applicable. We 

recommend that confirmed registrants 

arrive reasonably early, but no earlier 

than 45 minutes prior to the start of the 

meeting, to allow additional time to 

clear security. Security measures 

include the following: 

• Presentation of government-issued 

photographic identification to the 

Federal Protective Service or Guard 

Service personnel. 

• Inspection of vehicle’s interior and 

exterior (this includes engine and trunk 

inspection) at the entrance to the 

grounds. Parking permits and 

instructions will be issued after the 

vehicle inspection. 

• Inspection, via metal detector or 

other applicable means of all persons 

brought entering the building. We note 

that all items brought into CMS, 

whether personal or for the purpose of 

presentation or to support a 

presentation, are subject to inspection. 

We cannot assume responsibility for 

coordinating the receipt, transfer, 

transport, storage, set-up, safety, or 

timely arrival of any personal 

belongings or items used for 

presentation or to support a 

presentation. 

Note: Individuals who are not registered in 

advance will not be permitted to enter the 

building and will be unable to attend the 

meeting. The public may not enter the 

building earlier than 45 minutes prior to the 

convening of the meeting. 

All visitors must be escorted in areas other 

than the lower and first floor levels in the 

Central Building. 

Authority: 5 U.S.C. App. 2, section 10(a). 

(Catalog of Federal Domestic Assistance 

Program No. 93.773, Medicare—Hospital 

Insurance; and Program No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program) 

Dated: October 17, 2012. 

Patrick Conway, 

CMS Chief Medical Officer and Director, 

Center for Clinical Standards and Quality, 

Centers for Medicare & Medicaid Services. 

[FR Doc. 2012–26124 Filed 10–23–12; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Native Employment Works 

(NEW) Program Plan Guidance and 

Report Requirements. 

OMB No.: 0970–0174. 

Description: The Native Employment 

Works (NEW) program plan is the 

application for NEW program funding. 

As approved by the Department of 

Health and Human Services (HHS), it 

documents how the grantee will carry 

out its NEW program. The NEW 

program plan guidance provides 

instructions for preparing a NEW 

program plan and explains the process 

for plan submission every third year. 

The NEW program report provides 

information on the activities and 

accomplishments of grantees’ NEW 

programs. The NEW program report and 

instructions specify the program data 

that NEW grantees report annually. 


wreier-aviles on DSK5TPTVN1PROD with